Form 4: Heartflow Executive Sells Shares
Insider Transaction (Form 4)
Campbell Rogers, Chief Medical Officer of Heartflow, Inc., sold 9,219 shares of common stock on August 17, 2026 for $41.23 per share.
Summary
- Option exercise/conversion: acquired 9,219 Common Stock at $19.00 ($175,161) on August 17, 2026; holds 95,678 after (Direct).
- Open-market sale: disposed of 9,219 Common Stock at $41.23 ($380,099) on August 17, 2026; holds 86,459 after (Direct).
- Option exercise/conversion: disposed of 9,219 Stock Options on August 17, 2026; holds 82,972 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $380,099 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Campbell Rogers — Officer (Chief Medical Officer)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-17 | Option exercise/conversion | Common Stock | 9,219 | $19 | $175.2K | 95,678 |
| 2026-08-17 | Open-market sale | Common Stock | 9,219 | $41 | $380.1K | 86,459 |
| 2026-08-17 | Option exercise/conversion | Stock Options | 9,219 | — | — | 82,972 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-17 | Option exercise/conversion (9,219 shares) |
| 2026-08-17 | Open-market sale (9,219 shares) |
| 2026-08-17 | Option exercise/conversion (9,219 shares) |
Keywords
insider transaction, Form 4, HTFL, Heartflow, Inc., bearish, Campbell Rogers
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.